Advances in and prospects of immunotherapy for prostate cancer

This publication has 159 references indexed in Scilit:

• Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity
  Advanced Science, 2024
• Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction
  Clinical and Translational Medicine, 2024
• Single‐cell RNA‐sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone
  Clinical and Translational Medicine, 2022
• Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
  Clinical and Translational Medicine, 2022
• Tumor‐associated macrophages promote prostate cancer progression via exosome‐mediated miR‐95 transfer
  Journal of Cellular Physiology, 2020
• Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
  Advanced Healthcare Materials, 2020
• Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
  Advanced Materials, 2019
• Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
  JAMA Oncology, 2019
• Multifaceted Immunomodulatory Nanoliposomes: Reshaping Tumors into Vaccines for Enhanced Cancer Immunotherapy
  Advanced Functional Materials, 2017
• Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
  International Journal of Cancer, 2013